Advances create opportunities: Implementing the major tenets of the new unstable angina guidelines in the emergency department

Annals of Emergency Medicine

Volumn 38, Issue 3, 2001, Pages 241-248

  Pollack Jr , Charles V ^a,b   Gibler, W Brian ^a,b  

^a PENNSYLVANIA HOSPITAL   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; DALTEPARIN; ENOXAPARIN; EPTIFIBATIDE; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TIROFIBAN;

ARTICLE; EMERGENCY WARD; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

EID: 0034824473     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2001.117944     Document Type: Article

References (32)

1. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)
2. Predictors of myocardial infarction in emergency room patients
3. A computer-driven protocol to aid in the diagnosis of emergency room patients with acute chest pain
4. A computer protocol to predict myocardial infarction in emergency department patients with chest pain
5. Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room
6. Impact of physician experience on triage of emergency room patients with acute chest pain at three teaching hospitals
7. Evaluation of chest pain in the emergency department
8. Chest pain centers: Diagnosis of acute coronary syndromes
9. Evaluation and risk stratification of patients with chest pain in the emergency department: Predictors of life-threatening events
10. Comprehensive strategy for the evaluation and triage of the chest pain patient
11. Reducing lengths of stay for patients hospitalized with chest pain using medical practice guidelines and opinion leaders
12. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making
13. Heparin
14. Low-molecular-weight heparin during instability in coronary artery disease
15. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease
16. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease
17. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: Results of the Thrombolysis in Myocardial infarction (TIMI) 11B Trial
18. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science. Part 7: The era of reperfusion. Section 1: Acute coronary syndromes (acute myocardial infarction)
19. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina
20. Antithrombotic agents in coronary artery disease
21. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology
22. Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris
23. Combination therapy with tirofiban and enoxaparin in acute coronary syndromes
24. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
25. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
26. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
27. Does earlier administration of eptifibatide reduce death and MI in patients with acute coronary syndromes?
28. Unfulfilled potential: Underuse of glycoprotein IIB/IIIA inhibitors in acute coronary syndrome patients in the ED
29. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention